This year’s 340B eligibility recertification period for hospitals will start Aug. 14 and end Sept. 11, the U.S. Health Resources [...] …
Year: 2023
The U.S. Health Resources and Services Administration (HRSA) this week published notices from drug makers Amgen and Vertex about refunds [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health care providers almost certainly will have to accept new 340B reporting requirements in order to get unfettered access to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
340B INDUSTRY LEADER SPOTLIGHT
Tracy Jones, Midwest Regional Director & National Director of Advocacy, AIDS Healthcare Foundation
I grew up on the Eastside of Cleveland, Ohio in the inner city.
Read More »
Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations
…
The U.S. Senate Finance Committee apparently remains on track to vote Wednesday on a pharmacy benefit manager reform bill with [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
RWC-340B Backs Senate Bill That Would Let Ryan White Clinics Cover HIV Prevention Drugs and Services
Ryan White Clinics for 340B Access (RWC-340B) last week praised a new bill in the U.S. Senate that would let [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The National Association of Community Health Centers (NACHC) announced yesterday that its board has chosen Dr. Kyu Rhee, now CVS [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B drug pricing program may incentivize hospitals and other covered entities to buy expensive preventative HIV medications over low-cost [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Generic drug manufacturer Amring Pharmaceuticals is giving 340B covered entities refunds for overcharges on 14 products between the first quarter [...] …